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 Functional immunoglobulin genes are assem-
bled by V-(D)-J joining, a process catalysed 
by the RAG1/RAG2 recombinase. The func-
tionally rearranged Ig variable (IgV) regions can 
then be diversifi ed by somatic hypermutation 
or gene conversion; the immunoglobulin con-
stant (IgC) region can be exchanged by switch 
recombination (allowing the switch from IgM 
to IgG, IgA, or IgE). Somatic hypermutation, 
gene conversion, and switch recombination are 
all dependent on activation-induced deaminase 
(AID) ( 1 – 4 ). 
 A variety of lines of evidence (for review see 
references [ 5, 6 ]) reveal that AID acts by deami-
nating deoxycytidine residues to deoxyuridine 
(dU) at sites within the immunoglobulin loci, 
generating dU:deoxyguanosine (dG) lesions. Thus, 
genetic and biochemical assays show that AID 
is able to deaminate cytidine in single-stranded 
DNA with a local sequence preference that ac-
cords with the localization of in vivo somatic 
mutation hotspots; antibody gene diversifi cation 
pathways are also altered in B cells that carry 
disruptions in the pathways that process uracil 
in DNA ( 7 – 23 ). 
 Uracil excision by the uracil-DNA glyco-
sylase (uracil- N -glycolase [UNG]) is envisioned 
to play a central role in AID-triggered immuno-
globulin gene diversifi cation ( 7 – 9, 11, 12, 17, 
21 – 23 ). The transversion mutations at C:G pairs 
observed during IgV somatic hypermutation are 
proposed to be a consequence of DNA synthe-
sis over the UNG-generated abasic site in the 
IgV; switch recombination is proposed to be, 
in large part, achieved through UNG-mediated 
excision of the AID-generated uracils in the 
vicinity of the immunoglobulin switch region. 
Although such a DNA deamination scheme for 
antibody gene diversifi cation enjoys widespread 
support, the ability of active-site mutants of UNG 
to restore switch recombination in in vitro 
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 Activation-induced deaminase (AID) catalyses deamination of deoxycytidine to deoxyuri-
dine within immunoglobulin loci, triggering pathways of antibody diversifi cation that are 
largely dependent on uracil-DNA glycosylase (uracil- N -glycolase [UNG]). Surprisingly 
effi cient class switch recombination is restored to  ung  /  B cells through retroviral 
delivery of active-site mutants of UNG, stimulating discussion about the need for UNG ’ s 
uracil-excision activity.  In this study, however, we fi nd that even with the overexpression 
achieved through retroviral delivery, switching is only mediated by UNG mutants that 
retain detectable excision activity, with this switching being especially dependent on 
MSH2. In contrast to their potentiation of switching, low-activity UNGs are relatively 
ineffective in restoring transversion mutations at C:G pairs during hypermutation, or in 
restoring gene conversion in stably transfected DT40 cells. The results indicate that UNG 
does, indeed, act through uracil excision, but suggest that, in the presence of MSH2, 
effi cient switch recombination requires base excision at only a small proportion of the 
AID-generated uracils in the S region. Interestingly, enforced expression of thymine-DNA 
glycosylase (which can excise U from U:G mispairs) does not (unlike enforced UNG or 
SMUG1 expression) potentiate effi cient switching, which is consistent with a need either 
for specifi c recruitment of the uracil-excision enzyme or for it to be active on single-
stranded DNA. 
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 Figure 1.  Class switching in  ung   /   B cells after retroviral delivery of mutant UNGs.  (A) Experimental strategy with schematic representation of 
the retroviral vector used for UNG delivery . (B) Representative fl ow cytometric plots of switching to IgG1 by  ung   /   B cells after retroviral delivery of 
mutant mouse UNGs. The proportion of retrovirally infected (GFP + -positive) cells that have switched to IgG1 is indicated in the top right quadrant of each 
two-dimensional plot, with the sIgG1 profi le of the gated GFP + cells shown below. (C) Compilation of the results of multiple comparisons of switching to 
IgG1 achieved with different mutant mouse UNGs. The histogram presents the results of 13 independent experiments represented by the different sym-
bols (each using B cells prepared from a single mouse), with each mutant being analyzed in at least 4 separate experiments. To facilitate comparison of 
the results obtained in different experiments, a common symbol is used to depict the results obtained in a single experimental set. To facilitate compari-
son of overall switching profi ciency of the different UNG mutants, as deduced from multiple experiments, the means in the histograms are presented as 
values plus the SD that were normalized to 20% switching by wild-type UNG. The switching achieved using the D147N, D147G, (D147N,H270L), and 
(D147N,N206V) mutants differs signifi cantly from that achieved with wild-type UNG (P  < 0.05 for the single mutants; P  < 0.001 for the double mutants). 
(D) Expression of the different UNG mutants analyzed by Western blot of extracts from the retroviral packaging cells. A Western blot for GFP provides a 
control. The N206V mutation prevents recognition by the anti-UNG antibody, although the UNG-N206V mutant yields uracil-excision activity and sup-
ports switch recombination (C and  Fig. 3 C ). A nonspecifi c band recognized by the anti-UNG antibody is indicated by an asterisk. (E) The amino acid posi-
tions mutagenized in mouse UNG (yellow) are highlighted on a structure of human UNG (red) cocrystallized with a U-containing DNA fragment (blue; 
pdb 1SSP [ 36 ]) in which U is fl ipped out of the DNA helix and into the enzyme active site. The area surrounding the active site has been zoomed in from 
the whole structure (inset). Residue numbering is as in mouse UNG nuclear isoform. 
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assays was a major surprise, and it has triggered controversy 
about the importance of uracil excision in antibody gene diver-
sifi cation ( 24 – 28 ). 
 We revisit the ability of UNG mutants to partake in 
 immunoglobulin gene diversifi cation, and fi nd that those UNG 
mutants that, on retroviral delivery, are capable of restoring 
switch recombination to UNG-defi cient B cells still retain 
uracil-excision activity both in vivo and in vitro. The results 
suggest that the ability of UNG mutants that retain  < 1% 
of the specifi c uracil-excision of the wild-type enzyme to 
potentiate effi  cient switch recombination likely refl ects, in part, 
the heavy overexpression associated with retroviral delivery, 
but is also an indication that uracil excision at only a small 
proportion of AID-generated uracils may suffi  ce for switch 
recombination, a conclusion that is consistent with the pro-
posals of other studies concerning switch-associated DNA 
breaks ( 29 – 31 ). 
 RESULTS 
 Restoration of class switching by retroviral delivery 
of mutant UNGs 
 We fi rst sought to recapitulate the fi ndings of Begum et al. 
( 25 ) that switching could be eff ectively restored to  ung   /   B 
cells by retroviral delivery of UNG mutants carrying amino 
acid substitutions at their active sites. Constructs were gener-
ated encoding mutant versions of the nuclear isoform of 
mouse UNG with the choice of mutants guided both by the 
identity of the mutants studied by Begum et al. ( 25 ), as well 
as by various structural and kinetic analyses of human UNG, 
to which mouse UNG is 95% identical. 
 We fi nd that single amino-acid substitution mutants of 
residues that participate in catalyzing the cleavage of the glyco-
sidic bond (D147N or D147G, H270L, and N206V [ 32 – 36 ]) 
are all able to complement the switching defi ciency of B cells 
from  ung   /   mice in the retroviral reconstitution assay, whereas 
no evident restoration is obtained with the double UNG mu-
tants (D147N,H270L) and (D147N,N206V) ( Fig. 1 ). This 
is entirely in keeping with (and extends upon) a previous 
work ( 25 ). Interestingly, combining D147N with mutation 
of residue L274 still allows effi  cient restoration of switching. 
Residue L274 does not partake in the actual hydrolytic catalysis, 
but instead is inserted into the DNA helix upon uracil fl ip-
ping, with mutation of this residue signifi cantly diminishing 
UNG activity by reducing the stability of the DNA – UNG 
complex ( 32, 36 ). 
 Restoration of switching by mutant UNGs is affected 
by MSH2 defi ciency 
 Several explanations can be envisioned to account for the effi  -
cacy with which the UNGs carrying single active-site muta-
tions are able to restore switching to B cells from  ung   /   mice. 
One is that they retain suffi  cient uracil-excision activity to allow 
switch recombination to proceed in vivo. A second (the interpre-
tation favored by Begum et al. ( 24, 25 ]) is that UNG fulfi ls some 
unidentifi ed role in switch recombination that is dependent 
neither on its uracil-excision nor on its uracil-binding activity. 
A third possibility is that mere binding of the catalytically com -
promised UNG mutants to the dU:dG lesions generated by 
AID-targeted deamination creates a physical disturbance that 
is suffi  cient to potentiate switch recombination by a pathway 
that does not require uracil excision. 
 Previous work has shown that, in the absence of UNG, 
switching can nevertheless proceed (albeit with greatly reduced 
effi  cacy) through a pathway that depends on the MSH2 mis-
match recognition protein, presumably depending on MSH2/
MSH6 recognition of the initiating dU:dG lesion ( 7, 11 ). One 
could imagine that binding of a catalytically compromised UNG 
mutant to the dU:dG lesions could enhance switch recombi-
nation through this MSH2-dependent pathway, which is a 
possible exemplifi cation of the third type of scenario envi-
sioned in the previous paragraph. 
 We therefore asked whether the restoration of switching by 
the mutant UNGs was dependent on MSH2, and we tested this 
by retroviral delivery to B cells from  ung   /   msh2   /   double-
knockout mice. It is evident that although the D147N, D147G, 
and H270L single amino-acid substitution mutants of UNG are 
all able to reconstitute switching in B cells from these double-
knockout mice, they are consistently less active than the wild-
type enzyme in this regard ( Fig. 2 ). This is in contrast to what 
was observed with B cells from the  ung   /   single-knockout mice, 
where the UNG single-point mutants were equally or more 
potent as compared with the wild-type enzyme in restoring 
switching in the retroviral infection assay ( Fig. 1 C ). 
 Figure 2.  Class switching in  ung   /   msh2   /   B cells after retroviral 
delivery of mutant UNGs. (A) Representative fl ow cytometric plots pre-
sented as described in the legend to  Fig. 1 B . (B) Compilation of the results 
of three separate experiments represented by the different symbols, with 
the bars representing the averages. Switching by all the UNG mutants dif-
fers signifi cantly from that achieved with the wild-type enzyme (P  < 0.05). 
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This suggested that the switch-potentiating activity of these 
proteins might be at least partially dependent on their uracil-
excision activity. We therefore wished to investigate the ex-
tent to which the switch-potentiating activity of the diff erent 
mutant UNGs correlated with their ability to excise uracil 
from DNA. 
 Uracil-excision activity of mutant UNGs 
 Although Begum et al. ( 25 ) failed to detect uracil-excision 
activity in extracts of mammalian cells expressing their mouse 
UNG mutants carrying single amino-acid substitutions at their 
 These results revealed that the restoration of switching by 
the mutant UNGs was, although more dependent on MSH2 
than the switching by wild-type UNG, nevertheless certainly not 
wholly dependent on an MSH2-dependent backup  pathway. 
 Figure 3.  Mutant UNGs that support switching retain uracil-exci-
sion activity.  (A) Assay for uracil-excision activity by recombinant UNGs 
produced in  E. coli . 10   g extracts of  E. coli (  ung ) transformants ex-
pressing His-tagged versions of the indicated mouse UNG variants were 
incubated with 0.5 pmol of FITC-labeled, U-containing single-stranded 
oligonucleotide substrate. After incubation with apyrimidinic endonucle-
ase and subsequent PAGE, uracil excision is evident from conversion of 
the fl uorescently labeled 42-mer substrate (S) into the 26-mer product (P). 
Undiluted extracts were used, except where indicated. A Western blot 
using an anti-histidine tag antiserum was used to control for expression 
levels. (B) Assay for uracil-excision activity in extracts of  ung   /   DT40 
cells transfectants expressing wild-type or mutant FLAG-tagged mouse 
UNGs. Samples (5   g protein, or a dilution where specifi ed) of whole-cell 
extracts were assayed for uracil-excision activity as described in A, but 
with the extracts preincubated with the UNG-specifi c inhibitor Ugi where 
indicated. (right) An anti-FLAG Western blot to control for expression 
levels. (C) Assay for uracil-excision activity in extracts of  ung   /   mouse B 
cells that have been transduced with the indicated UNG-expressing retro-
viral vectors. Extracts (which were assayed undiluted) were prepared 4 d 
after retroviral transduction, and the proportion of retrovirally infected 
cells (as judged by GFP fl uorescence) in each population is indicated be-
low each lane. Endogenous SMUG1 activity was neutralized by preincu-
bating the extracts with anti-SMUG1 PSM1 antibody ( 11 ). 
 Figure 4.  Comparison of endogenous UNG expression with that 
achieved after gene delivery. (A) uracil-excision activity in whole-cell 
extracts of pIRES-hygro[FLAG-UNG] transfectants of  ung   /   DT40 as com-
pared with that in parental  ung +/+ DT40. Extracts were assayed undiluted 
or with a 10   2 dilution, as indicated. (B) Uracil-excision activity in extracts 
of B cells from either wild-type ( ung +/+ ) mice or from  ung   /   mice that 
have been transduced with pMX-UNG (UNG) or empty pMX retroviral 
vector (Vctr). The nominal dilutions of the extracts used are indicated, and 
have been normalized according to the percentage of GFP + cells to control 
for differences in the effi ciency of retroviral transduction. (C) UNG expres-
sion monitored by Western blot in whole-cell extracts of B cells from 
 ung +/+ or  ung   /   mice that had been transduced with either pMX-UNG or 
empty vector and cultured for 3 d. The fi lters were subsequently stripped 
and reprobed with an anti-PCNA antibody to provide a loading control. 
(D) Uracil-excision activity in extracts of B cells from  ung   /   mice that have 
been transduced with retroviral vectors expressing wild-type or D147N 
UNG as compared with that in extracts of (LPS + IL4)-activated B cells 
from wild-type ( ung +/+ ) mice. The nominal dilutions of the extracts used 
are indicated, normalized as in B. A minor band whose migration position 
(arrowhead) is slightly slower than the canonical oligonucleotide deamina-
tion product (P) refl ects a weak activity in the extracts, which cleaves the 
substrate oligonucleotide just 5  of the target uracil; after uracil excision, 
this minor band disappears, comigrating with the product P. 
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activity in the oligonucleotide cleavage assays are ineff ective 
at potentiating switching. 
 Mutant UNGs are defective in an IgV gene conversion assay 
 Apart from its role in class switching, UNG is also needed for 
IgV gene conversion, as well as for the introduction of trans-
version mutations at C:G pairs during hypermutation ( 8, 11, 
12, 17, 21, 23 ). We wondered whether the low specifi c ac-
tivity D147N mutant could substitute for wild-type UNG in 
these pathways of antibody diversifi cation as it did in class 
switching. Chicken DT40 B cells defi cient in UNG activity 
are ineff ective at IgV gene conversion, and instead diversify 
their IgV genes by the introduction of transition mutations at 
C:G pairs ( 8, 12 ). However, although stable transfection of a 
wild-type UNG construct allowed a restoration of gene con-
version and transversion mutations at C:G pairs (as well as 
some mutations at A:T), no such restoration was obtained with 
D147N UNG ( Table I ). 
 Retroviral transduction yields substantial UNG 
overexpression 
 This ability of the D147N mutant to restore class switching 
in the retroviral infection assay, but not restore IgV gene 
conversion/transversions at C:G pairs in the stably transfected 
DT40 cells, might be explained in part by the considerable diff er-
ence in the assay systems. In whole-cell extracts of  ung   /   DT40 
cells that have been stably transfected with the pIRESHyg 
expression plasmid, the level of UNG activity is of a simi -
lar order to that in the parental  ung +/+ DT40 line ( Fig. 4 A ). 
However, in contrast, retroviral infection of mouse  ung   /   B 
cells with the pMX-UNG retrovirus results in a level of UNG 
activity that is approximately two orders of magnitude higher 
than that in normal  ung +/+ mouse B cells ( Fig. 4 B ). In fact, 
whereas we and others (Kavli, B., personal communication) 
have found that the level of UNG protein in unfractionated 
whole-cell extracts of mouse B cells is below the limits of de-
tection in Western blots using anti-UNG peptide antiserum, a 
band is readily detectable in extracts of B cells that have been 
transduced with the pMX-UNG retrovirus ( Fig. 4 C ). 
 Retrovirally transduced UNGs do not restore C:G 
transversions in hypermutation 
 In addition to the switch recombination event itself, the induc-
tion of switch recombination in mouse B cells is accompanied 
active site, analogous mutants of human UNG have been found 
to display residual uracil-excision activity (between 0.05 and 
0.5% that of the wild type) after expression in  Escherichia coli 
( 28, 34, 35, 37 ). We suspect that this discordance refl ects 
an insensitivity of the uracil-excision assay used by Begum 
et al. ( 25 ). 
 We fi nd that the D147N mouse UNG mutant does (just 
like its human counterpart) display residual catalytic activity, as 
monitored by comparative kinetic analysis of wild-type and 
recombinant mouse UNGs purifi ed from  E. coli . Thus, whereas 
wild-type mouse UNG gave a K M of 0.39  ± 0.09   M and  k cat 
of 7.5  ± 0.6 s   1 on a single-stranded U-containing oligode-
oxyribonucleotide substrate as judged by a fl uorescence-based 
assay (see Materials and methods), the mouse D147N mutant 
gave a similar K M (0.37  ± 0.12   M), but an   1,000-fold re-
duced  k cat (6.5  × 10   3  ± 6  × 10   4 s   1 ). This diff erence in  k cat is 
similar to that observed between the wild-type and D147N-
equivalent mutant of human UNG ( 34, 37 ). 
 We therefore went on to test whether this uracil-excision 
activity associated with the mutant UNGs was also detectable 
in whole-cell extracts using the gel-based oligonucleotide as-
say (rather than a high-sensitivity fl uorescence-based assay of 
purifi ed protein). Despite its low turnover activity, the mouse 
D147N mutant was expressed at suffi  cient levels in whole-
cell extracts of  ung -defi cient transformants of  E. coli , in stable 
transfectants of  ung   /   chicken DT40 B cells, and in the ret-
rovirally transduced B cells from  ung   /   mice for its catalytic 
activity to be clearly detectable in such assays ( Fig. 3, A – C ). 
Furthermore, the same result was obtained for the mouse 
UNG mutants carrying single amino-acid substitutions (H270L 
and N206V;  Fig. 3, A and C ). However, despite comparable 
expression levels, no activity could be detected for any of the 
mutants carrying two mutations in active-site residues, although 
activity was readily detectable for the [D147N, L274A] in which 
the L274 residue is not implicated in the excision of the uracil 
itself. Thus, all the UNG mutants that had been able to po-
tentiate class switching in the retroviral infection assay exhib-
ited uracil-excision activity in the oligonucleotide cleavage 
assay ( Fig. 3 ), whereas those defective in the uracil-excision 
assay failed to give detectable switching. Therefore, the most 
straightforward interpretation of the data is that a low level of 
uracil-excision activity suffi  ces for effi  cient (though signifi cantly 
MSH2-dependent) switching in the retroviral infection assay; 
however, UNG mutants with undetectable uracil-excision 
 Table I.  IgV  diversifi cation in UNG-reconstituted  ung   /   DT40 cells a 
Gene 
 conversions
Mutations at C:G Mutations at 
 A:TTotal Tv
UNG-WT 14 50 16 13
UNG-D147N 1 b 56 0 0
 a The IgV  genes were sequenced from the sorted sIgM-loss population from 7 independent transfectants expressing wild-type mouse UNG (52 mutated sequences) and 
5 independent transfectants expressing the D147N mutant (29 mutated sequences). All events identifi ed in more than one sequence within a given transfectant population 
were counted only once to avoid overestimation caused by repeat counting of dynastically related events.
 b This putative gene conversion event comprises two consecutive C→T transitions; it cannot be defi nitively concluded that these do not refl ect separate single-nucleotide 
substitutions.
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 Figure 5.  Comparison of class switching in  ung   /   B cells expressing SMUG1 (or G87Y) through transgenesis versus retroviral delivery. 
(A) Representative fl ow cytometric plots showing switching to IgG1 in purifi ed  ung   /   mouse B cells that have been retrovirally infected with the pMX 
retroviral vector encoding the indicated uracil-excision enzymes. Switching was assayed as in  Fig. 1 , with the proportion of retrovirally infected (GFP + ) 
cells that have switched to IgG1 indicated in the top right quadrants. (B) Comparative effi ciency of switching restoration by the indicated uracil-excision 
enzymes as monitored in multiple experiments using B cells from  ung   /   mice. Symbols are used as described in the legend to  Fig. 1 so as to facilitate 
comparisons of the results obtained in individual sets of experiments. There is no signifi cant difference between the extent of switching achieved with UNG 
and SMUG1 or SMUG[G87Y] and CTRL. (C) Comparison of the effi cacy of retrovirally delivered and transgenically expressed SMUG1 in facilitating switch 
recombination. (top) A fl ow cytometric comparison of switching to IgG1 in samples of (LPS + IL4)-stimulated splenic B cells from  ung   /   msh2   /   mice 
that have been infected with the pMX vector alone or with derivatives directing expression of human SMUG1 or mouse UNG. The percentages of infected 
cells (GFP + ) that switched to IgG1 are indicated above each plot. (bottom) A fl ow cytometric comparison of switching to IgG1 as analyzed at day 8 of 
culture in samples of (LPS + IL4)-stimulated splenic B cells from  ung   /   msh2   /   mice that did or did not carry a transgene directing enforced B cell –
 specifi c expression of human SMUG1. A parallel analysis performed on cultured B cells from UNG-profi cient mice is shown on the right. The proportion of 
B cells (judged by CD45R[B220] staining) that switched to IgG1 is indicated. (D) Comparison of SMUG1-mediated uracil-excision activity in extracts (10  μ g 
protein) of LPS-activated B cells from  ung   /   msh2   /   mice that either carry a SMUG1 transgene (day 4 after stimulation) or that were infected with 
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might act more potently in promoting switching if intro-
duced by retroviral infection. This is indeed the case. As with 
the low-activity UNG mutants, SMUG1 is equally (or slightly 
more) potent than wild-type UNG in potentiating switching 
after retroviral delivery to  ung   /   B cells ( Fig. 5, A and B ), 
although it is marginally less potent than wild-type UNG when 
assayed using B cells from  ung   /   msh2   /   mice ( Fig. 5 C ). 
In contrast, transgenically expressed SMUG1, although clearly 
able to trigger switching, is signifi cantly less potent than en-
dogenous UNG ( Fig. 5 C ). The greater extent of switching 
achieved with retrovirally delivered (as opposed to transgeni-
cally expressed) SMUG1 could in part be caused by a slightly 
higher level of SMUG1 activity achieved ( Fig. 5 D ). How-
ever, the issue may not merely be one of the extents of over-
expression. It is possible that when  ung   /   B cells are cultured 
for 2 d before delivery of the uracil-excision enzyme by ret-
roviral transduction, the cells have accumulated large num-
bers of dU:dG lesions that may  “ prime ” the reaction. Indeed, 
human UNG-defi cient B cells have been found to accumu-
late uracil in their DNA ( 29 ). In contrast, in  ung +/+ B cells, 
the dU:dG lesions generated in each cell cycle are recognized 
for either repair or switch recombination by endogenous 
UNG, such that large numbers of dU:dG lesions do not have 
occasion to accumulate. 
 Analysis of the G87Y active-site mutant of SMUG1 pro-
vides further evidence that uracil-excision activity is required 
for class switching. This mutant has completely lost catalytic 
activity ( Fig. 5 E ) ( 40 ), and it has simultaneously lost the abil-
ity to trigger class switch recombination ( Fig. 5 A, B ). 
 Retroviral delivery of thymine-DNA glycosylase (TDG) does 
not restore switching 
 Given the potent restoration of switching by both SMUG1 
and catalytically compromised UNGs in the retroviral assay, 
we were curious to know whether overexpression of any 
uracil-excision enzyme could potentiate switching in this 
 assay. Strikingly, retroviral delivery of mouse TDG (which 
excises U efficiently from U:G mispairs, but is ineffective 
on U in the context of single-stranded DNA) gives little evi-
dent switch recombination, although TDG polypeptide and 
its uracil-excision activity are readily detectable in cell ex-
tracts ( Fig. 6 ). 
 DISCUSSION 
 The results presented here confi rm previous fi ndings that 
active site mutants of UNG are potent in stimulating class 
switch recombination in the retroviral infection assay ( 25 ). 
However, our data reveal that those mutants that facilitate 
by the introduction of point mutations into the S  region 
( 38, 39 ). As with somatic hypermutation in the vicinity of 
the IgV segment, the transversion mutations at C:G pairs are 
dependent on UNG-mediated uracil excision, presumably 
through replication over the abasic site. In wild-type mice, 
30 – 40% of the mutations at C:G pairs are transversions; 
this falls to  < 10% in UNG-defi cient animals (unpublished 
data) ( 19, 25 ). 
 It seemed possible that the restoration of switch recombi-
nation in B cells from  ung   /   mice that is achieved through 
retroviral transduction of low-activity UNG mutants might 
simply refl ect the fact that the overexpression achieved through 
retroviral delivery compensates for the low specifi c activity of 
the mutant UNG enzyme, thereby allowing a normal level of 
uracil excision to take place. If that were the case, one would 
expect that retroviral delivery of low-activity UNGs would, 
in the same cells, also restore transversion  mutations at C:G 
pairs in the S  region. This is not the case. Analysis of mutations 
in the region fl anking the 5  -side of the S  repeats (the preS  
region) from UNG-defi cient B cells that had been infected 
with the H270L UNG retrovirus revealed that although class 
switching had been eff ectively restored, the preS  mutations 
were still restricted to transitions at C:G pairs (all 73 independent 
mutations at C:G pairs were transitions). Similarly, with the 
D147N UNG retrovirus (which also fully restored switching 
in the retrovirally transduced cells), 46 out of 50 independent 
C:G mutations were transitions. Thus, the level of mutant 
UNG overexpression that is suffi  cient to effi  ciently restore 
switching in retrovirally infected  ung   /   B cells appears insuf-
fi cient to restore C:G transversions during hypermutation 
of the preS  region. Indeed, despite the heavy overexpres-
sion associated with retroviral transduction, the level of uracil-
excision activity detected in extracts of  ung   /   B cells that 
have been transduced with a retrovirus expressing the D147N 
mutant is still substantially lower (approximately an order of 
magnitude on a per cell basis) than in activated B cells from 
wild-type mice ( Fig. 4 D ). 
 SMUG1 potentiation of switching is enhanced 
by retroviral delivery 
 We wondered whether the effi  cacy with which switching is 
restored by low-activity uracil-excision enzymes, in part, re-
fl ects the sensitivity of the retroviral switching assay. We have 
previously observed that enforced expression, through trans-
genesis, of another uracil-excision enzyme (single-stranded 
monofunctional uracil DNA glycosylase [SMUG] 1) only 
partially rescues switch recombination in B cells of  ung   /   
msh2   /   mice ( 9 ). We therefore wished to test whether SMUG1 
the SMUG1 retroviral construct (day 3 after infection). Preincubation with the PSM1-neutralizing anti-SMUG1 antibody confi rms the origin of the uracil-
excision activity. (E) Comparison of SMUG1 and SMUG1-G87Y expression. (top) SMUG1 expression in cells transfected with the indicated pMX-based 
retroviral vector was assessed by Western blot analysis using an anti-FLAG mAb. (middle) A Western blot for the vector-encoded GFP provides a control 
for infection effi ciency. (bottom) The uracil-excision activity of the SMUG1 and SMUG1-G87Y mutant were assessed in stably transfected DT40 cells 
(because DT40 cells do not have detectable endogenous SMUG1 activity [ 9, 23 ]), as described in  Fig. 3 , except that all reactions were preincubated in the 
presence of 0.5 U of Ugi to inhibit endogenous chicken UNG ( 9 ). 
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switching retain uracil-excision activity that is readily detect-
able in extracts of transduced B cell, whereas those mutants 
that show no uracil-excision activity have lost the ability to 
potentiate switching. Thus, in distinction to Begum et al. ( 25 ), 
our results do not call into doubt the proposal that UNG 
acts in class switching through uracil excision, but actually 
provide further support for it, showing a correlation between 
UNG exci sion capability and immunoglobulin class switching. 
This analysis is buttressed by the fi nding that SMUG1, which 
is a quite distinct uracil-excision enzyme, but not an enzyma-
tically inactive SMUG[G87Y] mutant, can substitute for UNG 
in the retroviral switching assay. 
 It is nevertheless striking that mutants of UNG that retain 
 < 1% of the specifi c activity of the parental enzymes are still as 
good (and, in some cases, better) than the parental enzymes 
in potentiating switching in the retroviral infection assay. This 
probably refl ects, in large part, the overexpression of UNG 
that is achieved by retroviral infection, generating a substantial 
excess of UNG activity in the infected cells over that which 
is necessary to achieve switching. Indeed, humans bearing 
UNG[F255S] are defi cient in secondary antibody  diversifi -
cation ( 17 ), likely because the mutant protein is mistargeted 
to the mitochondrion ( 29 ). However, the same mutant UNG 
functions effi  ciently in the retroviral switching assay ( 25 ), with 
others having previously suggested that one explanation for 
this discrepancy could be the overexpression associated with the 
retroviral assay ( 5, 29, 41 ). 
 It is, however, notable that the level of uracil-excision 
activity in the same cultured B cells that have been infected 
with mutant UNG retroviruses is not suffi  cient to achieve a 
restoration of transversion mutations at C:G pairs in the preS 
region. Thus, we do not believe that overexpression entirely 
explains the effi  cacy of low-activity UNG mutants in these 
retroviral switching assays. Rather, we suspect that uracil ex-
cision at only a small proportion of AID-generated S region-
associated dU:dG pairs may suffi  ce for switch recombination. 
Thus, analysis of S region mutation spectra in B cells from 
 ung   /   msh2   /   mice reveals that several hundred dU:dG 
lesions are generated in the vicinity of the S regions during 7 d 
of culture with LPS ( 42 ). It may be that uracil excision at 
only a small proportion of these dU:dG lesions suffi  ces for the 
initiation of switch recombination. This would certainly be 
consistent with the data of Zarrin et al. ( 31 ), who showed that 
the introduction of a single, staggered double-strand break in 
donor plus accepter S regions suffi  ced for the induction of 
switch recombination. In contrast, the introduction of trans-
version mutations at C:G pairs during IgV/S  hypermutation 
will presumably correlate directly with the proportion of dU 
residues from which the uracil is excised. 
 It is interesting that the switching triggered by the low-
activity UNG mutants is more dependent on MSH2 than that 
by wild-type UNG. There are several possible interpretations 
of this fi nding. A variety of studies have suggested that, quite 
apart from providing a backup mechanism for recognizing 
the dU:dG lesion when UNG is absent, MSH2 likely plays 
an important role in resolving the dU:dG lesions into switch 
recombination in normal mice ( 43 – 46 ). Work from the 
Stavnezer and Selsing laboratories has revealed that when S  
is deleted so as to greatly reduce the number of target sites 
for AID-mediated deoxycytidine deamination, the switching 
 Figure 6.  Retroviral expression of TDG does not restore class 
switching in  ung   /   B cells.  (A) Comparison of switching to IgG1 by 
B cells from  ung   /   mice that have been infected with the pMX retroviral 
vector encoding GFP alone or GFP together with either UNG or FLAG-
tagged TDG, as monitored in multiple experiments indicated by the differ-
ent symbols. The difference between the switching obtained with TDG and 
that obtained in the CTRL sample is not signifi cant. (B) Analysis of FLAG-
TDG expression in retrovirally infected B cells as monitored by Western 
blot using an anti-FLAG mAb; the band marked by an asterisk is probably 
sumoylated TDG ( 37 ). A Western blot for the vector-encoded GFP provides 
a control for infection effi ciency. (C) Flow cytometric plots showing 
switching to IgG1 in purifi ed B cells from an  ung   /   msh2   /   mouse that 
has been infected with the pMX retroviral vector encoding GFP alone or 
GFP together with either UNG or FLAG-tagged TDG. Switching was as-
sayed as in  Fig. 1 , with the proportion of retrovirally infected (GFP + ) cells 
that have switched to IgG1 indicated in the top right quadrants. (D) Dem-
onstration of TDG-encoded uracil-excision activity in extracts of retrovirus 
producing cells that have been transfected with the pMX retroviral vector 
encoding FLAG-tagged TDG. (left) Uracil-excision activity was monitored 
on a U-containing single-stranded oligonucleotide (which is not a sub-
strate for TDG), whereas a double-stranded oligonucleotide containing a 
U:G mismatch is used on the right. Because TDG, UNG, and SMUG1 will all 
act as uracil-DNA glycosylases (UDG) on such a dsDNA oligonucleotide 
substrate, extracts were preincubated with Ugi (to inhibit UNG) and the 
PSM1 mAb (to inhibit SMUG1) when wishing to restrict the assay to TDG. 
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PCR-amplifi ed using oligonucleotides CATGATCGGCCAGAAGAC-
CCT and GTCACAGCTCCTTCCAGTTGA and subcloned into pCR 
blunt II TOPO (Invitrogen). Point mutations were introduced into this 
construct by the QuickChange strategy (Stratagene) using the following 
oligonucleotides for each indicated mutation: D147N (GTTGTCATTCT-
GGGACAGAATCCCTATCACGGACCTAATC and GATTAGGTCC-
GTGATAGGGATTCTGTCCCAGAATGACAAC); N206V (GGTGTC-
CTCCTCCTCGTCGCCGTCCTCACTG and CAGTGAGGACGGC-
GACGAGGAGGAGGACACC); D147G (GTTGTCATTCTGGGACAG-
GGTCCCTATCACGGACCTAATC and GATTAGGTCCGTG ATA-
GGGACCCTGTCCCAGAATGACAAC); H270L (CCATGTTCTGCA-
GACAGCTCTCCCCTCCCCGCTGTCGGTG and CACCGACAGC-
GGGGAGGGGAGAGCTGTCTGCAGAACATGG); and L274A (GAC-
AGCTCACCCCTCCCCGGCGTCGGTGCACAGAGGGTTCC and 
GGAACCCTCTGTGCACCGACGCCGGGGAGGGGTGAGCTGTC). 
The UNG variants were excised from this vector using fl anking EcoRI sites 
and subcloned into the retroviral vector pMXs-ires-GFP (gift from T. Kitamura, 
University of Tokyo, Tokyo, Japan; abbreviated here as pMX) ( 50 ). The 
correct orientation of the insert was determined by digestion with ApaLI. 
For expression in DT40 cells, mouse UNG, D147N, and (D147N,H270L) 
variants were subcloned into the eukaryotic expression vector pIRESHyg3 
(Clontech Laboratories, Inc.) by introducing an NheI site at the N terminus 
and using the EcoRV site from the pCR-blunt II TOPO vector. A FLAG 
tag was then brought in at the N terminus by introducing the annealed 
oligonucleotides  GTACAATGGACTACAAGGACGATGATGACAAGG 
and  CTAGCCTTGTCATCATCGTCCTTGTAGTCCATT into the BsrGI 
and NheI sites of pIRESHyg3. For bacterial expression, the indicated mouse 
UNG mutants were subcloned as NheI – EcoRI fragments into pTrcHis 
(Invitrogen), resulting in the 6xHis-tagged versions of the enzymes. 
 Cloning of full-length human SMUG1 into pEGFP-N3 (Clontech 
Laboratories, Inc.) has been previously described ( 9 ). A derivative containing 
the G87Y SMUG1 mutation that had been created by oligonucleotide 
mutagenesis was generously provided by Z. Yang (Medical Research Coun-
cil Laboratory of Molecular Biology, Cambridge, UK). The EGFP coding 
region in these vectors was then replaced with a FLAG tag by introducing 
the annealed oligonucleotides  GATCCGACTACAAGGACGATGACGA-
CAAGTGAGC and  GGCCGCTCACTTGTCGTCATCGTCCTTGTA-
GTCG into the BamHI – NotI-digested SMUG and G87Y vectors. The 
C-terminally tagged SMUG and G87Y were then subcloned EcoRI – NotI 
into pMXs-ires-GFP. 
 I.M.A.G.E. clone 6416434 containing the full-length mouse TDG cDNA 
was obtained from Geneservice, Ltd. The coding sequence was PCR-amplifi ed 
using oligonucleotides  AAGAATTCATGGACGCAGAGGCCGCGCGCA 
and  ACACGCGGCCGCTCCTAAGCGTGGCTCTCTTCTT containing 
EcoRI and NotI sites, respectively, and subcloned into the corresponding 
sites of pCDNA3.1(+). An N-terminal FLAG tag was introduced using the 
annealed oligonucleotides  GATCCATGGACTACAAGGACGATGATGA-
CAAGG and  AATTCCTTGTCATCATCGTCCTTGTAGTCCATG 
into BamHI and EcoRI sites. The BamHI – NotI insert was then subcloned 
into pMXs-ires-GFP. 
 Mouse B cell cultures and retroviral infection.  Lymphocytes from 
C57B/6,  ung   /   , and  ung   /   msh2   /   mice were purifi ed from homoge-
nized spleens by centrifugation over a density cushion of Lympholyte-M 
(Cedarlane Laboratories, Ltd.). Naive B cells were then enriched by deple-
tion of CD43 + cells using anti-CD43 – coupled magnetic microbeads and LD 
columns in a MACS separator (Miltenyi Biotech) according to the manufac-
turer ’ s instructions. B cells (10 6 ) were seeded in 24-well plates in 1 ml RPMI 
10% FBS, 0.05 mM 2-mercaptethanol in the presence of 50  μ g/ml LPS 
(Sigma-Aldrich) and 50 ng/ml recombinant mouse IL4 (R & D Systems). 
Ecotropic retroviruses were produced by transfecting 2  μ g of the pMXs-ires-
GFP constructs into Plat-E packaging cells ( 51 ). Transfections were per-
formed in 6-well plates using Fugene (Roche), and the medium was replaced 
by fresh medium after 24 h. Transfection effi  ciency was similar for all the 
constructs (80 – 90%), as judged by the proportion of GFP + cells. B cells were 
becomes much more dependent on MSH2 ( 44, 45, 47 ). This 
has led to the proposition that MSH2 acts to convert AID-
instigated single-strand DNA nicks into the double-strand 
breaks necessary for switch recombination ( 29, 30 ). In terms 
of this model, one could well envision that the low-activity 
UNG mutants would only act to generate relatively few 
 single-strand nicks in the S regions; resolution to switch re-
combination might therefore be highly dependent on MSH2. 
In contrast, with wild-type UNG, uracil excision is likely to 
occur at a much higher proportion of sites, possibly leading 
directly to the creation of staggered double-strand breaks, 
and thus resulting in the diminished dependence on MSH2. 
 Although the results reveal that the retroviral delivery of 
even very low-activity UNG mutants (as well as of wild-type 
SMUG1) is suffi  cient to yield effi  cient switching, the same 
eff ect is not achieved through overexpression of TDG, despite 
the sensitivity of the retroviral assay. Although TDG acts on 
deoxythymidine:dG mispairs, biochemical characterization of 
TDG from various species reveals that it is a very potent uracil-
excision enzyme when monitored on dU:dG, in fact, show-
ing a preference for dU:dG over deoxythymidine:dG ( 48, 49 ). 
The issue therefore arises as to why TDG cannot substitute 
eff ectively for UNG or SMUG1 in switch recombination; 
infection with the retroviral TDG construct certainly results 
in plenty of uracil-excision activity, as monitored biochemically 
on a dU:dG-containing oligonucleotide substrate ( Fig. 6 D ). 
One possible explanation is that UNG might harbor a motif 
that enables it to be recruited to the dU:dG lesion in the 
immunoglobulin locus ( 24 ), and that such a motif is shared 
by SMUG1, but not TDG. A distinct possibility is that the 
critical substrate for uracil excision to achieve switch recom-
bination is not a dU:dG mispair, but rather dU in the context 
of single-stranded DNA. Thus, like the AID-mediated de-
amination event itself, the uracil excision may need to occur 
on a single-stranded DNA substrate to trigger switching. 
Certainly, both UNG and SMUG1 (but not TDG) are ac-
tive on dU in the context of single-stranded DNA. Further 
analysis of mutant uracil-excision enzymes should shed light 
on this issue. 
 In conclusion, the results presented in this study provide 
direct evidence that class switch recombination requires ura-
cil excision, with the role of UNG in antibody gene diversi-
fi cation hinging on the protein ’ s catalytic activity rather than 
just the mere presence of the enzyme. The demonstration 
that some, but not all, uracil-excision enzymes (UNG and 
SMUG1, but not TDG) can function in antibody diversifi cation 
may provide insight into the nature of the uracilated DNA 
substrate (single- versus doubled-stranded), as well as the circum-
stances necessary for its access (e.g., during replication, as pre-
viously suggested [ 9 ]). 
 MATERIALS AND METHODS 
 Expression vectors for UNGs.  The full-length cDNA for the nuclear 
isoform of mouse UNG (UNG2) was obtained from the Integrated Molec-
ular Analysis of Genomes and their Expression (I.M.A.G.E.) consortium 
(I.M.A.G.E. clone 4009947) through Geneservice, Ltd. The coding region was 
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